Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6092678 | Gastroenterology | 2015 | 13 Pages |
Abstract
Among patients with BE and confirmed LGD, rates of progression to a combined end point of HGD and EAC were lower among those treated with RFA than among untreated patients. Although selection bias cannot be excluded, these findings provide additional evidence for the use of endoscopic ablation therapy for LGD.
Keywords
EACIMCLGDEMRHGDIQRRFAEsophageal adenocarcinomaEMR, endoscopic mucosal resectionClinical settingradiofrequency ablationGastrointestinalhigh-grade dysplasialow-grade dysplasiaEsophageal cancerEradicationIntestinal metaplasiainterquartile rangeBarrett's esophagushazard ratioPreventionintramucosal carcinoma
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Aaron J. Small, James L. Araujo, Cadman L. Leggett, Aaron H. Mendelson, Anant Agarwalla, Julian A. Abrams, Charles J. Lightdale, Timothy C. Wang, Prasad G. Iyer, Kenneth K. Wang, Anil K. Rustgi, Gregory G. Ginsberg, Kimberly A. Forde, Phyllis A. Gimotty,